What is difference between CAPEX and OPEX in business?
Posted on19 Aug 2015
Comments0
These are the two useful terminology what a strategic management professionals in pharma business. Capital expenditures (CAPEX or capex) are expenditures altering... Read More
Boehringer Ingelheim and Circuit Therapeutic’s collaboration to discover novel obesity drug
Posted on19 Aug 2015
Comments0
Boehringer Ingelheim and Circuit Therapeutics have announced a second collaboration using Circuit’s proprietary optogenetics technology platform. This new three-year collaboration will focus... Read More
What is immuno-oncology?
Immuno-oncology is a new area of medicine that focuses on the development and delivery of therapies that improve the body’s intrinsic potential... Read More
Sanofi, Evotec and Apeiron Biologics enter collaboration to develop immuno-oncology treatments
Sanofi has entered a research collaboration and license agreement with Evotec and Apeiron Biologics to discover and develop first-in-class small molecule-based immuno-oncology... Read More
What is Moving annual total (MAT)? How it is calculated?
The moving annual total (MAT) is the total value of a variable, such as sales figures for a product, over the course... Read More
R-PHARM US Acquires IXEMPRA(R) (ixabepilone) From Bristol-Myers Squibb and Launches U.S. Commercial Operations
R-PHARM US announces the acquisition of IXEMPRA (ixabepilone) from Bristol-Myers Squibb (BMY). IXEMPRA received marketing approval from the U.S. Food and Drug... Read More
What is importance of compound annual growth rate (CAGR) in pharma marketing? How to calculate?
The compound annual growth rate (CAGR) is a useful measure of growth over multiple time periods. It can be thought of as... Read More
Check your understanding in Product Recall #drug regulatory affairs
Take a short competency test to understand your knowledge regarding drug recall and FDA’s involvement in product recall.
AstraZeneca & Isis Pharmaceuticals partnership to discover and develop antisense drugs
Posted on04 Aug 2015
Tagsantisense oligonucleotides, AstraZeneca, AstraZeneca and Isis Pharmaceuticals, Isis Pharmaceuticals
Comments0
About the strategic collaboration: AstraZeneca and Isis Pharmaceuticals, Inc. announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic... Read More
Pfizer and Synthon Deal for generic version of the originator medicine Copaxone®
Pfizer Inc. and Synthon, an international pharmaceutical company specializing in the development of complex generic medicines, today announced they have entered into... Read More